What is Rofenac 50mg?
Rofenac 50mg is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and other symptoms of arthritis of the joints (eg, osteoarthritis), such as inflammation, swelling, stiffness, and joint pain. However, Rofenac 50mg does not cure osteoarthritis and will help you only as long as you continue to use it.
Rofenac 50mg topical 3% gel is also used to treat actinic keratosis, a skin problem that may become cancerous if not treated. The exact way that topical Rofenac 50mg helps this condition is unknown.
Rofenac 50mg topical solution is used to treat pain and swelling caused by osteoarthritis of the knees.
Rofenac 50mg topical patch is used to treat acute pain caused by minor strains, sprains, and contusions (bruises).
Rofenac 50mg is available only with your doctor's prescription.
Rofenac 50mg indications
Carefully consider the potential benefits and risks of Rofenac 50mg delayed-release tablets and other treatment options before deciding to use Rofenac 50mg delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.
Rofenac 50mg delayed-release tablets are indicated:
- •
- For relief of the signs and symptoms of osteoarthritis
- •
- For relief of the signs and symptoms of rheumatoid arthritis
- •
- For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
How should I use Rofenac 50mg?
Use Rofenac 50mg as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Rofenac 50mg comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Rofenac 50mg refilled.
- Do not apply Rofenac 50mg to infected skin; open wounds; or red, swollen, or peeling skin.
- Wash your hands immediately before and after using Rofenac 50mg.
- Wash the affected area and dry completely before using Rofenac 50mg.
- To apply Rofenac 50mg, dispense 10 drops at a time onto the knee or into your hand. Spread Rofenac 50mg evenly around the front, back, and sides of the knee. Repeat until you have used the whole dose.
- Be sure that you cover your entire knee with your dose of Rofenac 50mg. Do not use more than the recommended amount.
- Do not apply sunscreens, cosmetics, insect repellants, other topical medicines, or any other substance to the treated area until it is completely dry.
- Do not put on clothes over the treated area until it is completely dry.
- Do not wrap, bandage, or apply heat to the treated area.
- Let the treated skin dry before touching it or letting it touch anyone else's skin.
- Do not shower, bathe, or wash the treated area for at least 30 minutes after you use Rofenac 50mg.
- If you miss a dose of Rofenac 50mg, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Rofenac 50mg.
Uses of Rofenac 50mg in details
Use: Labeled Indications
Ankylosing spondylitis (delayed-release tablets only): Acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis.
Dysmenorrhea (immediate-release tablets only): Treatment of primary dysmenorrhea.
Migraine (powder for oral solution only): Acute treatment of migraine attacks with or without aura in adults.
Osteoarthritis (immediate-release, extended-release, and delayed-release tablets; capsules [Zorvolex]; and suppositories [Canadian product] only): Relief of signs and symptoms of osteoarthritis.
Pain
Capsules/immediate-release tablets only: Relief of mild to moderate acute pain.
Injection only: Management of mild to moderate pain and moderate to severe pain (alone or in combination with opioid analgesics) in adults.
Rheumatoid arthritis (immediate-release, extended-release, and delayed-release tablets; and suppositories [Canadian product] only): Relief of signs and symptoms of rheumatoid arthritis.
Off Label Uses
Gout, treatment (acute flares)
Data from a limited number of trials support the efficacy of Rofenac 50mg in the treatment of acute gout flares.
Based on the 2012 American College of Rheumatology guidelines for management of gout, nonsteroidal anti-inflammatory drugs are effective and recommended agents in the treatment of acute gout flares.
Rofenac 50mg description
A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
Rofenac 50mg dosage
Carefully consider the potential benefits and risks of Rofenac 50mg extended-release tablets, and other treatment options before deciding to use Rofenac 50mg extended-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.
After observing the response to initial therapy with Rofenac 50mg extended-release tablets the dose and frequency should be adjusted to suit an individual patient’s needs.
For the relief of osteoarthritis, the recommended dosage is 100 mg daily.
For the relief of rheumatoid arthritis, the recommended dosage is 100 mg daily. In the rare patient where Rofenac 50mg extended-release tablets 100 mg/day is unsatisfactory, the dose may be increased to 100 mg twice a day if the benefits outweigh the clinical risks of increased side effects.
Different formulations of Rofenac 50mg (Rofenac 50mg enteric-coated tablets; Rofenac 50mg extended-release tablets; Rofenac 50mg potassium immediate-release tablets) are not necessarily bioequivalent even if the milligram strength is the same.
Rofenac 50mg interactions
See also:
What other drugs will affect Rofenac 50mg?
Aspirin: Concomitant administration of Rofenac 50mg and aspirin is not recommended because Rofenac 50mg is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.
Anticoagulants: While studies have not shown Rofenac 50mg to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs. Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including Rofenac 50mg, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
Digoxin, Methotrexate, Cyclosporine: Rofenac 50mg, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs. Ingestion of Rofenac 50mg may increase serum concentrations of digoxin and methotrexate and increase cyclosporineís nephrotoxicity. Patients who begin taking Rofenac 50mg or who increase their Rofenac 50mg dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs. They should be observed closely, particularly if renal function is impaired. In the case of digoxin, serum levels should be monitored.
Lithium: Rofenac 50mg decreases lithium renal clearance and increases lithium plasma levels. In patients taking Rofenac 50mg and lithium concomitantly, lithium toxicity may develop.
Oral Hypoglycemics:
Rofenac 50mg does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic agents. There are rare reports, however, from marketing experiences, of changes in effects of insulin or oral hypoglycemic agents in the presence of Rofenac 50mg that necessitated changes in the doses of such agents. Both hypo- and hyperglycemic effects have been reported. A direct causal relationship has not been established, but physicians should consider the possibility that Rofenac 50mg may alter a diabetic patientís response to insulin or oral hypoglycemic agents.
Diuretics: Rofenac 50mg and other NSAIDs can inhibit the activity of diuretics. Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels.
Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of Rofenac 50mg. Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of Rofenac 50mg therapy.
Protein Binding
In vitro, Rofenac 50mg interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin. Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of Rofenac 50mg in human serum.
Drug/Laboratory Test Interactions
Effect on Blood Coagulation: Rofenac 50mg increases platelet aggregation time but does not affect bleeding time, plasma thrombin clotting time, plasma fibrinogen, or factors V and VII to XII. Statistically significant changes in prothrombin and partial thromboplastin times have been reported in normal volunteers. The mean changes were observed to be less than 1 second in both instances, however, and are unlikely to be clinically important. Rofenac 50mg is a prostaglandin synthetase inhibitor, however, and all drugs that inhibit prostaglandin synthesis interfere with platelet function to some degree; therefore, patients who may be adversely affected by such an action should be carefully observed.
Rofenac 50mg side effects
See also:
What are the possible side effects of Rofenac 50mg?
Ocular
Transient burning and stinging were reported in approximately 15% of patients across studies with the use of Rofenac 50mg ophthalmic solution, 0.1%. In cataract surgery studies, keratitis was reported in up to 28% of patients using Rofenac 50mg ophthalmic solution, 0.1%, although in many of these cases keratitis was initially noted prior to the initiation of treatment. Elevated intraocular pressure following cataract surgery was reported in approximately 15% of patients undergoing cataract surgery. Lacrimation complaints were reported in approximately 30% of case studies undergoing incisional refractive surgery. The following adverse reactions were reported in approximately 10% or less of the patients: abnormal vision, acute elevated IOP, blurred vision, conjunctivitis, corneal deposits, corneal edema, corneal opacity, corneal lesions, discharge, eyelid swelling, eye pain, injection (redness), iritis, irritation, itching, lacrimation disorder, and ocular allergy.
Systemic
The following adverse reactions were reported in 3% or less of the patients: abdominal pain, asthenia, chills, dizziness, facial edema, fever, headache, insomnia, nausea, pain, rhinitis, viral infection and vomiting.
Clinical Practice
The following reactions have been identified during postmarketing use of topical Rofenac 50mg ophthalmic solution, 0.1% in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to topical Rofenac 50mg ophthalmic solution, 0.1%, or a combination of these factors, include corneal erosion, corneal infiltrates, corneal perforation, corneal thinning, corneal ulceration and epithelilal breakdown.
TO REPORT SUSPECTED ADVERSE REACTIONS, contact Altaire Pharmaceuticals, Inc., at 1-800-258-2471 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Rofenac 50mg contraindications
See also:
What is the most important information I should know about Rofenac 50mg?
Rofenac 50mg in all formulations, Cataflam, Voltaren, and Voltaren-XR, is contraindicated in patients with known hypersensitivity to Rofenac 50mg and Rofenac 50mg-containing products. Rofenac 50mg should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to Rofenac 50mg have been reported in such patients.
Active ingredient matches for Rofenac 50mg:
List of Rofenac 50mg substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| ROFENAC-D | |
| RUMOL-D (India) | |
| RUMOL-D topical gel 1 % w/w x 40g (Crystal Variety) | $ 0.98 |
| Ruz-diclofenac® | |
| Safeguard SR | |
| Safeguard SR 100 mg+200 mcg Tablet (Pulse Parmaceuticals Pvt.Ltd.) | $ 0.10 |
| SAFEGUARD 100MG/200MCG TABLET SR 1 strip / 15 tablet srs each (Pulse Parmaceuticals Pvt.Ltd.) | $ 1.98 |
| Saiflam MR | |
| Saiflam MR 500+250+50 Tablet (Saimark Biotech Pvt. Ltd.) | $ 0.03 |
| Satio D | |
| Satio D 10+50 Tablet (Brooks Pharmaceuticals) | $ 0.07 |
| Sedase D | |
| Sedase D 50+10 Tablet (Ortin Laboratories Ltd) | $ 0.08 |
| Sedase D 50+10 Pharma Plus Tablet (Ortin Laboratories Ltd) | $ 0.07 |
| Sefenac | |
| Sefenac 75 mg Injection (SPM Drugs Pvt. Ltd.) | $ 0.02 |
| Selclo Pep | |
| Selclo Pep 50+10 Tablet (Waksman Selman Pharmaceuticals Pvt. Ltd.) | $ 0.06 |
| Sendic | |
| Sendic 50+10 Tablet (Hamax Pharmaceuticals) | $ 0.06 |
| Sep K | |
| Sep K 10+50 Tablet (Rut Pharma) | $ 0.08 |
| SEP K TABLET 1 strip / 10 tablets each (Rut Pharma) | $ 0.55 |
| Sep K Tablet (Rut Pharma) | $ 0.06 |
| Sepdase D | |
| Sepdase D 50+10 Tablet (Elixir Formulations) | $ 0.05 |
| Sepdase D 50+10 Jocund India Tablet (Elixir Formulations) | $ 0.06 |
| SEPDASE D 50MG/10MG TABLET 1 strip / 10 tablets each (Elixir Formulations) | $ 0.75 |
| Sepdase D 50 mg/10 mg Tablet (Elixir Formulations) | $ 0.08 |
| Septa D | |
| Septa D 50+10 Tablet (Rekvina Pharmaceuticals) | $ 0.07 |
| SEPTA D 50 MG/10 MG TABLET 1 strip / 10 tablets each (Rekvina Pharmaceuticals) | $ 0.70 |
| Septa D 50 mg/10 mg Tablet (Rekvina Pharmaceuticals) | $ 0.07 |
| Serador D | |
| Serador D 50+10 Tablet (Adore Healthcare) | $ 0.06 |
| Seraflam D | |
| Seraflam D 50+10 Tablet (Osho Pharma Pvt.Ltd.) | $ 0.04 |
| Seration DF | |
| Seration DF 50+10 Tablet (Harson Lab Pvt. Ltd.) | $ 0.07 |
| SERATION DF 50MG/10MG TABLET 1 strip / 10 tablets each (Harson Lab Pvt. Ltd.) | $ 0.83 |
| Seration DF 50 mg/10 mg Tablet (Harson Lab Pvt. Ltd.) | $ 0.08 |
| Seratodase D | |
| Seratodase D 50+15 Tablet (Marc Laboratories Pvt. Ltd.) | $ 0.08 |
| Serb D | |
| Serb D 50+10 Tablet (Ester Formulations) | $ 0.06 |
| SERENGY (India) | |
| SERENGY inj 25 mg x 1 mL x 1ml (Unikind) | |
| Seridol Plus | |
| Seridol Plus 50+10 Tablet (Cataliq Laboratories Pvt. Ltd.) | $ 0.07 |
| Serlik | |
| Serlik 10+50 Tablet (Teblik Drugs Ltd.) | $ 0.06 |
| Sernase D | |
| Sernase D 50+10 Tablet (Allied Chemicals & Pharmaceuticals Pvt.Ltd.) | $ 0.06 |
| Sero D | |
| Sero D 10+50 Tablet (Aan Pharma Pvt Ltd) | $ 0.06 |
| Serodal | |
| Serodal 50+10 Tablet (Dallas Pharmaceuticals) | $ 0.06 |
| Seroz D | |
| Seroz D 50+10 Tablet (Medoz Pharmaceuticals) | $ 0.08 |
| SEROZ D 50MG/10MG TABLET 1 strip / 10 tablets each (Medoz Pharmaceuticals) | $ 0.77 |
| SERROZ D 50MG/10MG TABLET 1 strip / 10 tablets each (Medoz Pharmaceuticals) | $ 0.66 |
| Seroz D 50 mg/10 mg Tablet (Medoz Pharmaceuticals) | $ 0.08 |
| Serpet D | |
| Serpet D 50+10 Tablet (Suzikem Drugs Pvt. Ltd.) | $ 0.05 |
| Serraden Plus | |
| Serraden Plus 50+10 Tablet (Eden Healthcare) | $ 0.07 |
| Serrodase D | |
| Serrodase D 50+10 Tablet (Sienna Formulations Pvt Ltd.) | $ 0.06 |
See 919 substitutes for Rofenac 50mg | |
References
- DailyMed. "DICLOFENAC EPOLAMINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "diclofenac". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "diclofenac". http://www.drugbank.ca/drugs/DB00586 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Rofenac 50mg are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Rofenac 50mg. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Rofenac 50mg drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 1 | 100.0% | |
4 consumers reported price estimates
Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?The below mentioned numbers have been reported by ndrugs.com website users about whether the Rofenac 50mg drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
| Users | % | ||
|---|---|---|---|
| Expensive | 2 | 50.0% | |
| Not expensive | 2 | 50.0% | |
4 consumers reported time for results
To what extent do I have to use Rofenac 50mg before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 1 week and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Rofenac 50mg. To get the time effectiveness of using Rofenac 50mg drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 1 week | 1 | 25.0% | |
| 1 day | 1 | 25.0% | |
| 5 days | 1 | 25.0% | |
| 2 weeks | 1 | 25.0% | |
26 consumers reported age
| Users | % | ||
|---|---|---|---|
| 30-45 | 13 | 50.0% | |
| 16-29 | 6 | 23.1% | |
| > 60 | 4 | 15.4% | |
| 6-15 | 2 | 7.7% | |
| 46-60 | 1 | 3.8% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
